King & Wood Mallesons advises UBS Wealth Management on $471 Million Oncology Impact Fund
King & Wood Mallesons has advised UBS Wealth Management, the world’s largest global wealth manager, on the final closing of its $471 million UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments.
Investments will be made in early stage oncology to accelerate the development of new cures. Cancer care is particularly appropriate for this kind of investment because of a supportive regulatory environment.